Postprandial variations in the cholesteryl ester transfer protein activity, phospholipid transfer protein activity and plasma cholesterol efflux capacity in normolipidemic men

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 13, Issue 1, 2003, Pages 28-36

  Syeda, F ^a   Senault, C ^b   Delplanque, B ^a   Le Roy, B ^c   Thaminy, A ^a   Gripois, D ^a   Blouquit, M F ^a   Ruelland, A ^d   Mendy, F ^e   Lutton, C ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

^d SERVICE DE RHUMATOLOGIE   (France)

^e 1 Parc du Bearn ^*  (France)

Author keywords

CETP; Cholesterol efflux; PLTP; Postprandial

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; FATTY ACID; HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPID TRANSFER PROTEIN; CARRIER PROTEIN; CETP PROTEIN, HUMAN; GLYCOPROTEIN; LIPID; MEMBRANE PROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CORRELATION ANALYSIS; FATTY ACID BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LIPID DIET; MALE; POSTPRANDIAL STATE; PROTEIN BLOOD LEVEL; PROTEIN ISOLATION; AGED; BLOOD; DIET RESTRICTION; FAT INTAKE; FOOD; KINETICS; MIDDLE AGED;

ADULT; AGED; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; DIETARY FATS; FASTING; FATTY ACIDS, NONESTERIFIED; FOOD; GLYCOPROTEINS; HUMANS; KINETICS; LIPIDS; LIPOPROTEINS, HDL; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHOSPHOLIPID TRANSFER PROTEINS;

EID: 0042967976     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-4753(03)80165-5     Document Type: Article

References (45)

1. Simons LA, Dwyer T, Simons J, Bernstein L, Mock P, Poonia NS, Balasubramaniam S, Baron D, Branson J, Morgan J, Roy P (1987) Chylomicrons and chylomicron remnants in coronary artery disease: a case control study. Atherosclerosis 65: 181-189
2. Groot PH, van Stiphout WA, Krauss XH, Jansen H, van Tol A, van Ramshorst E, Chin-on S, Hofman A, Cresswell SR, Havekes L (1991) Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 11: 653-662
3. Patsch JR, Miesenbôk G, Hopferwieser T, Mühlberger V, Knapp E, Dunn JK, Gotto AM Jr, Patsch W (1992) Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arterioscler Thromb 12: 1336-1345
4. Zilversmit DB (1979) Atherogenesis: a postprandial phenomenon. Circulation 60: 473-485
5. Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumenton AH, Tweedie-Hardman J, Kottie L, Kunitake ST, Havel RJ, Kane JP (1994) Triglyceride-rich lipoproteins isolated by selected-affinity antilipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb 14: 1767-1774
6. Hesler CB, Swenson TL, Tall AR (1987) Purification and characterization of a human plasma cholesteryl ester transfer protein. J Biol Chem 262: 2275-2282
7. Hill SA, McQueen MJ (1997) Reverse cholesterol transport: a review of the process and its clinical implications. Clin Biochem 30: 517-525
8. Tall AR, Granot E, Brocia R, Tabas I, Hesler C, Williams K, Denke M (1987) Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein. J Clin Invest 79: 1217-1225
9. Castro G, Fielding CJ (1985) Effects of postprandial lipemia on plasma cholesterol metabolism. J Clin Invest 75: 874-882
10. Tall AR, Sammett D, Granot E (1986) Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipidemia. J Clin Invest 77: 1163-1172
11. Dullaart RP, Groener JE, Van Wijk H, Sluiter WJ, Erkelens DW (1989) Alimentary lipidemia-induced redistribution of cholesteryl ester between lipoproteins. Studies in normolipidemic men. Arteriosclerosis 9: 614-622
12. Marcel YL, McPherson R, Hogue M, Czarnecka H, Zawadzki Z, Weech PK, Whitlock ME, Tall AR, Milne RW (1990) Distribution and concentration of cholesterol ester transfer protein in plasma of normolipidemic subjects. J Clin Invest 85: 10-17
13. Lassel TS, Guerin M, Auboiron S, Chapman MJ, Guy-Grand B (1998) Preferential cholesteryl ester acceptors among triglyceride-rich lipoproteins during alimentary lipidemia in normolipidemic subjects. Arterioscler Thromb Vasc Biol 18: 65-74
14. Redgrave TG, Small DM (1979) Quantification of the transfer surface phospholipid of chylomicrons to the high density lipoprotein fraction during the metabolism of chylomicrons in the rat. J Clin Invest 64: 162-171
15. Tollefson JH, Liu A, Albers JJ (1998) Regulation of plasma lipid transfer by human plasma phospholipid transfer protein. J Biol Chem 266: 4853-4861
16. Tu A, Nishida HI, Nishida T (1993) High density lipoprotein conversion mediated by human phospholipid transfer protein. J Biol Chem 268: 23098-23105
17. Jauhiainen M, Metso J, Palhman R, Blomquist S, van Tol A, Ehnholm C (1993) Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 268: 4032-4036
18. Wolfbauer G, Albers JJ, Oram JF (1999) Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochim Biophys Acta 1439: 65-76
19. von Eckardstein A, Jauhiainen M, Huang Y, Metso J, Langer C, Pussinen P, Wu S, Ehnholm C, Assmann G (1996) Phospholipid transfer protein mediated conversion of high density lipoprotein generates pre betal-HDL. Biochim Biophys Acta 1301: 255-262
20. Rye KA, Jauhiaienen M, Barter PJ, Ehnholm C (1998) Triglyceride- enrichment of high density lipoproteins enhances their remodeling by phospholipid transfer protein. J Lipid Res 39: 613-622
21. Riemens SC, Van Tol A, Sluiter WJ, Dullaart RP (1999) Acute and chronic effects of a 24-hour intravenous triglyceride emulsion challenge on plasma lecithin: cholesterol acyltransferase, phospholipid transfer protein, and cholesteryl ester transfer protein activities. J Lipid Res 40: 1459-1466
22. Rye KA, Clay MA, Barter PJ (1999) Remodelling of high density lipoproteins by plasma factors. Atherosclerosis 145: 227-238
23. Bruce C, Chouinard RA, Tall AR (1998) Plasma lipid transfer proteins, high density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr 18: 297-330
24. Fielding PE, Jackson EM, Fielding CJ (1989) Chronic dietary fat and cholesterol inhibit the normal postprandial stimulation of plasma cholesterol metabolism. J Lipid Res 30: 1211-1217
25. Sakr SW, Senault C, Vacher D, Fournier N, Girard-Globa A (1996) Oleic acid-rich fats increase the capacity of postprandial serum to promote cholesterol efflux from Fu5AH cells. Biochim Biophys Acta 1300: 49-55
26. de la Llera Moya M, Atger V, Paul JL, Fournier N, Moatti N, Giral P, Friday KE, Rothblat G (1994) A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb 14: 1056-1065
27. McPherson R, Mann CJ, Tall AR, Hogue M, Martin L, Milne RW, Marcel YL (1991) Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester tranfer protein activity and other lipoprotein variables. Arterioscler Thromb 11: 797-804
28. Damen J, Regts J, Scherphof G (1982) Transfer of [14C] phosphatidylcholine between liposomes and human plasma high density lipoprotein. Partial purification of a transfer-stimulating plasma factor using a rapid transfer assay. Biochim Biophys Acta 712: 444-452
29. Murdoch S, Carr MC, Hokanson JE, Brunzell JD, Albers JJ (2000) PLTP activity in premenopausal women: relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance. J Lipid Res 41: 237-244
30. Fournier N, Paul JP, Atger V, Cogny A, Soni T, de la Liera Moya M, Rothblat GH, Moatti N (1997) HDL phospholipid content and composition is a major factor determining cholesterol efflux capacity from Fu5AH cell to human serum. Arterioscler Thromb Vasc Biol 17: 2685-2691
31. Jian B, de la Liera Moya M, Ji Y, Wang N, Phillips MC, Swaney JB, Tall AR, Rothblat GH (1998) Scavenger receptor class B type I is a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J Biol Chem 267: 4541-4550
32. Durlach V, Attia N, Zahouani A, Leutenegger M, Girard-Globa A (1996) Postprandial cholesteryl ester transfer and high density lipoprotein composition in normotriglyceridemic non-insulin-dependent diabetic patients. Atherosclerosis 120: 155-165
33. Lottenberg SA, Lottenberg AM, Nunes VS, McPherson R, Quintao EC (1996) Plasma cholesteryl ester transfer protein concentration, high-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins in the fasting state and after a test meal are similar in Type II diabetics and normal controls. Atherosclerosis 127: 81-90
34. Contacos C, Barter PJ, Vrga L, Sullivan DR (1998) Cholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin. Atherosclerosis 141: 87-98
35. Son YS, Zilversmit DB (1986) Increased lipid transfer activities in hyperlipidemic rabbit plasma. Arteriosclerosis 6: 345-351
36. Sammet D, Tall AR (1985) Mechanisms of enhancement of cholesteryl ester transfer protein activity by lipolysis. J Biol Chem 11: 6687-6697
37. Barter PJ, Chang LB, Rajaram OV (1990) Sodium oleate promotes a redistribution of cholesteryl esters from high to low density lipoproteins. Atherosclerosis 84: 13-24
38. Masson D, Athias A, Lagrost L (1996) Evidence for electronegativity of plasma high density lipoprotein-3 as a one major determinant of human cholesteryl ester transfer protein activity. J Lipid Res 37: 1579-1590
39. Miller NE, Nanjee MN (1991) Evidence that reverse cholesterol transport is stimulated by lipolysis of triglyceride-rich lipoproteins. FEBS Lett 8: 132-134
40. Oka T, Kujiraoka T, Ito M, Egashira T, Nanjee NM, Miller NE, Metso J, Olkkonen VM, Ehnholm C, Jauhiainen M, Hattori H (2000) The distribution of phospholipid transfer protein (PLTP) in human plasma: presence of two forms of PLTP one catalytically active and the other inactive. J Lipid Res 41: 1651-1657
41. Syvânne M, Castro G, Dengremont C, De Geitere C, Jauhiainen M, Ehnholm C, Michelagnoli S, Franceschini G, Kahri J, Taskinen MR (1996) Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein. Atherosclerosis 127: 245-253
42. Desrumaux C, Athias A, Bessede G, Verges B, Farnier M, Persegol L, Gambert P, Lagrost L (1999) Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA. Arterioscler Thromb Vasc Biol 19: 266-275
43. Mero N, van Tol A, Scheek LM, Van Gent T, Labeur C, Rosseneu M, Taskinen MR (1998) Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities. J Lipid Res 39: 1493-1502
44. Cheung MC, Wolfbauer G, Albers JJ (1996) Plasma phospholipid mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters. Biochim Biophys Acta 1303: 103-110
45. Desrumeaux C, Athias A, Masson D, Gambert P, Lallemant C, Lagrost L (1998) Influence of the electrostatic charge of lipoprotein particles on the activity of the human plasma phospholipid transfer protein. J Lipid Res 39: 131-142